Stock Information
Zenas Biopharma Inc (ZBIO)
Ticker Symbol: ZBIO
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $1,109.61 mil
Piotroski score: 2
PE Ratio: N/A
EPS (TTM): -12.6677
Revenue (TTM): $0.36 M
Dividend Yield: N/A%
ROE: -73.55%
Latest News
-
Crude Oil Surges 4%; US Consumer Sentiment Declines In March
Fri, Mar 27, 2026 12:40 PM
-
Zenas BioPharma shares are trading lower after it announced it priced concurrent public offerings of $200 million of convertible senior notes and 5 million shares at $20 per share.
Fri, Mar 27, 2026 8:12 AM
-
Zenas Biopharma, Daqo New Energy And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Fri, Mar 27, 2026 8:10 AM
-
12 Health Care Stocks Moving In Friday's Pre-Market Session
Fri, Mar 27, 2026 8:05 AM
-
Why Newsmax Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket
Fri, Mar 27, 2026 6:00 AM
-
Zenas BioPharma Prices $300M Concurrent Offerings Of $200M 2.50% Convertible Senior Notes Due 2032 And 5M Shares At $20 To Fund Obexelimab Launch
Fri, Mar 27, 2026 1:58 AM
-
12 Health Care Stocks Moving In Thursday's After-Market Session
Thu, Mar 26, 2026 5:05 PM
-
Zenas BioPharma shares are trading lower after the company announced it commenced an underwritten public offering of convertible senior notes and shares of its common stock.
Thu, Mar 26, 2026 4:35 PM
-
Zenas BioPharma Announces Proposed Concurrent Public Offerings Of Convertible Senior Notes And Common Stock; Amounts Not Disclosed
Thu, Mar 26, 2026 4:04 PM
Key Financials
Financial data not available
